Annual CFO
-$136.16 M
+$37.27 M+21.49%
31 December 2023
Summary:
Rhythm Pharmaceuticals annual cash flow from operations is currently -$136.16 million, with the most recent change of +$37.27 million (+21.49%) on 31 December 2023. During the last 3 years, it has fallen by -$14.18 million (-11.62%). RYTM annual CFO is now -1851.51% below its all-time high of -$6.98 million, reached on 31 December 2015.RYTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$25.21 M
+$3.86 M+13.28%
30 September 2024
Summary:
Rhythm Pharmaceuticals quarterly cash flow from operations is currently -$25.21 million, with the most recent change of +$3.86 million (+13.28%) on 30 September 2024. Over the past year, it has increased by +$4.04 million (+13.80%). RYTM quarterly CFO is now -310.53% below its all-time high of -$6.14 million, reached on 30 June 2017.RYTM Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$124.42 M
+$4.04 M+3.14%
30 September 2024
Summary:
Rhythm Pharmaceuticals TTM cash flow from operations is currently -$124.42 million, with the most recent change of +$4.04 million (+3.14%) on 30 September 2024. Over the past year, it has increased by +$16.36 million (+11.62%). RYTM TTM CFO is now -1673.33% below its all-time high of -$7.02 million, reached on 31 March 2017.RYTM TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RYTM Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +21.5% | +13.8% | +11.6% |
| 3 y3 years | -11.6% | +37.2% | +7.6% |
| 5 y5 years | -119.4% | +25.0% | -11.6% |
RYTM Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -11.6% | +21.5% | at high | +53.0% | at high | +30.8% |
| 5 y | 5 years | -119.4% | +21.5% | at high | +53.0% | -11.6% | +30.8% |
| alltime | all time | -1851.5% | +21.5% | -310.5% | +53.0% | -1673.3% | +30.8% |
Rhythm Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$25.21 M(-13.3%) | -$124.42 M(-3.1%) |
| June 2024 | - | -$29.08 M(-28.6%) | -$128.45 M(-8.6%) |
| Mar 2024 | - | -$40.74 M(+38.7%) | -$140.47 M(+3.2%) |
| Dec 2023 | -$136.16 M(-21.5%) | -$29.38 M(+0.5%) | -$136.16 M(-3.3%) |
| Sept 2023 | - | -$29.25 M(-28.8%) | -$140.77 M(-11.2%) |
| June 2023 | - | -$41.09 M(+12.8%) | -$158.51 M(+1.5%) |
| Mar 2023 | - | -$36.43 M(+7.2%) | -$156.23 M(-9.9%) |
| Dec 2022 | -$173.43 M(+18.8%) | -$34.00 M(-27.6%) | -$173.43 M(-3.6%) |
| Sept 2022 | - | -$46.99 M(+21.1%) | -$179.90 M(+3.9%) |
| June 2022 | - | -$38.81 M(-27.6%) | -$173.07 M(+4.2%) |
| Mar 2022 | - | -$53.63 M(+32.5%) | -$166.10 M(+13.8%) |
| Dec 2021 | -$146.00 M(+19.7%) | -$40.47 M(+0.8%) | -$146.00 M(+8.4%) |
| Sept 2021 | - | -$40.16 M(+26.1%) | -$134.65 M(+10.8%) |
| June 2021 | - | -$31.84 M(-5.0%) | -$121.52 M(+1.8%) |
| Mar 2021 | - | -$33.53 M(+15.1%) | -$119.41 M(-2.1%) |
| Dec 2020 | -$121.98 M | -$29.12 M(+7.7%) | -$121.98 M(-2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$27.03 M(-9.1%) | -$125.08 M(-5.0%) |
| June 2020 | - | -$29.73 M(-17.6%) | -$131.65 M(+3.3%) |
| Mar 2020 | - | -$36.10 M(+12.0%) | -$127.47 M(+3.8%) |
| Dec 2019 | -$122.75 M(+97.8%) | -$32.22 M(-4.1%) | -$122.75 M(+10.1%) |
| Sept 2019 | - | -$33.60 M(+31.5%) | -$111.51 M(+17.6%) |
| June 2019 | - | -$25.55 M(-18.6%) | -$94.85 M(+16.0%) |
| Mar 2019 | - | -$31.38 M(+49.5%) | -$81.78 M(+31.8%) |
| Dec 2018 | -$62.06 M(+110.6%) | -$20.98 M(+23.9%) | -$62.06 M(+26.8%) |
| Sept 2018 | - | -$16.94 M(+35.8%) | -$48.96 M(+21.1%) |
| June 2018 | - | -$12.48 M(+7.1%) | -$40.43 M(+18.6%) |
| Mar 2018 | - | -$11.65 M(+47.8%) | -$34.09 M(+15.7%) |
| Dec 2017 | -$29.46 M(+26.9%) | -$7.88 M(-6.3%) | -$29.46 M(+36.5%) |
| Sept 2017 | - | -$8.42 M(+37.0%) | -$21.57 M(+64.0%) |
| June 2017 | - | -$6.14 M(-12.5%) | -$13.16 M(+87.5%) |
| Mar 2017 | - | -$7.02 M | -$7.02 M |
| Dec 2016 | -$23.22 M(+232.8%) | - | - |
| Dec 2015 | -$6.98 M | - | - |
FAQ
- What is Rhythm Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals annual CFO year-on-year change?
- What is Rhythm Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals quarterly CFO year-on-year change?
- What is Rhythm Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals TTM CFO year-on-year change?
What is Rhythm Pharmaceuticals annual cash flow from operations?
The current annual CFO of RYTM is -$136.16 M
What is the all time high annual CFO for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high annual cash flow from operations is -$6.98 M
What is Rhythm Pharmaceuticals annual CFO year-on-year change?
Over the past year, RYTM annual cash flow from operations has changed by +$37.27 M (+21.49%)
What is Rhythm Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of RYTM is -$25.21 M
What is the all time high quarterly CFO for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high quarterly cash flow from operations is -$6.14 M
What is Rhythm Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, RYTM quarterly cash flow from operations has changed by +$4.04 M (+13.80%)
What is Rhythm Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of RYTM is -$124.42 M
What is the all time high TTM CFO for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high TTM cash flow from operations is -$7.02 M
What is Rhythm Pharmaceuticals TTM CFO year-on-year change?
Over the past year, RYTM TTM cash flow from operations has changed by +$16.36 M (+11.62%)